Experts point out some pitfalls that medtech companies should be aware of when trying to raise capital.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Although transactions were down, they exceeded more than $450 million last month.
Eighty medtech transactions in Europe came in at a value of approximately $627.5 million.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Overall activity in deals jumped 11% in North America.
Device companies may also need to assess their product portfolios to provide a more comprehensive suite of tools, according to a new report.
Ernst & Young’s annual Pulse of the Industry report reveals decreasing global revenue and financing in the medtech industry.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.